Target ALSRNA Therapy for ALS: A Promising TreatmentWhile the precise mechanisms that lead to the development of amyotrophic lateral sclerosis (ALS) are still under investigation, several…Sep 9Sep 9
Target ALSHow FUS Fits into the Bigger RNA Protein PictureWhile the precise mechanisms that lead to the development of amyotrophic lateral sclerosis (ALS) are still under investigation, several…Mar 28Mar 28
Target ALSTherapeutic Target HDAC6 and ALSFor over a decade, histone deacetylase (HDAC) inhibitors have been investigated as anti-cancer agents that play a role in the death or cell…Feb 20Feb 20
Target ALSRNA Therapy for ALS: A Promising TreatmentWhile the precise mechanisms that lead to the development of amyotrophic lateral sclerosis (ALS) are still under investigation, several…Jan 17Jan 17
Target ALSWhat is AAV for Gene Therapy?Gene therapy is promising biotechnology with the potential to treat or cure diseases caused by a mutated gene. By introducing new genetic…Jan 2Jan 2
Target ALSJuvenile ALS: How Common is ALS in Your 20s?Juvenile Amyotrophic Lateral Sclerosis (JALS), in which symptoms begin to appear before the age of 25, affects fewer than 1,000 people in…Nov 29, 2023Nov 29, 2023
Target ALSThe Stages of ALS: Framing the Progression of a Nonlinear DiseaseWhat is ALS?Oct 24, 2023Oct 24, 2023
Target ALSALS and Nutrition: How Diet Impacts ALS PatientsAccording to the World Health Organization (WHO), the average person needs to regularly ingest a combination of cereals, legumes, fruits…Oct 2, 2023Oct 2, 2023
Target ALSWhat is Bulbar-Onset ALS? Six Things to Know.ALS typically begins either as weakness in the limbs, called limb (or spinal) onset, or difficulty in speaking or swallowing, termed bulbar…Aug 16, 2023Aug 16, 2023